Physician

Aditya G Parikh, M.D.

According to 2025 Medicare claims, Aditya Parikh, M.D. (NPI: 1588939938) practices advanced heart failure and transplant cardiology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PENN - MEDICAL GROUP (NPI: 1093725145; TIN: 232743545) and primary practice location at 19104-5127. Parikh is affiliated with the Penn Medicine Healthcare Partners, LLC (ACO ID: A5318), participating under the MSSP model.

Parikh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 498 traditional Medicare patients, billed 1,513 HCPCS/CPT codes, and received $67,343 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 925 prescription claims across 148 beneficiaries totaling $552,928 in drug costs, led by Vyndamax (Tafamidis). DME data shows 69 claims. Open Payments data shows 35 records totaling $53,585. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $6,805 to $552,928. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $7,222 and ending at $4,252.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	108	526	$44,438
2020	198	940	$75,881
2021	257	1,083	$93,910
2022	245	781	$72,627
2023	349	1,144	$78,674
2024	498	1,513	$67,343

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	16	112	$6,805
2016	18	170	$11,247
2017	33	308	$15,608
2018	24	217	$8,979
2019	33	129	$11,648
2020	80	435	$44,328
2021	113	1,131	$210,526
2022	135	954	$425,893
2023	139	664	$249,062
2024	148	925	$552,928

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	85	$7,413
2020	N/R	82	$3,780
2021	N/R	74	$3,032
2022	N/R	208	$10,224
2023	N/R	27	$789
2024	N/R	69	$977

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	45	45	$149
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	93	154	$111
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	50	192	$63
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	118	188	$13
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	426	572	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	12	360	$273,344
Jardiance	Empagliflozin	60	4,216	$79,356
Entresto	Sacubitril/Valsartan	57	3,415	$75,754
Farxiga	Dapagliflozin Propanediol	14	1,260	$22,252
Eliquis	Apixaban	22	1,020	$20,270

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	22	$326
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	18	$296
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	14	$226
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	15	$129

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	34	$16,646	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$36,939	ENDOTRONIX, INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aditya G. Parikh, M.D.?

Tedicare shows public-source Medicare data for Aditya G. Parikh, M.D. (NPI 1588939938), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aditya G. Parikh, M.D. have ACO affiliation data?

Aditya G. Parikh, M.D. is shown with ACO affiliation data for Penn Medicine Healthcare Partners, LLC (MSSP, ACO ID A5318).

What billing organization is linked to Aditya G. Parikh, M.D.?

Aditya G. Parikh, M.D. is linked to UNIVERSITY OF PENN - MEDICAL GROUP (billing NPI 1093725145) in the available physician profile data.

Does Aditya G. Parikh, M.D. have Open Payments data?

Aditya G. Parikh, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.